SCHEMBL20401310

SCHEMBL20401310

N#Cc1cccc(I)c1-c1cc(-c2cn(Cc3ccc(F)cc3F)nn2)nc(N)n1

nearest known ligand 0.57

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 20/20 0.57
▸ ADORA2B P29275 18/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30401167 0.83 ADORA2A (0.53) ADORA2AADORA2B
SCHEMBL20416811 0.83 ADORA2A (0.53) ADORA2AADORA2B
SCHEMBL20401473 0.80 ADORA2A (0.60) ADORA2AADORA2B
SCHEMBL20401366 0.78 ADORA2A (0.53) ADORA2AADORA2B
SCHEMBL23190410 0.78 ADORA2A (0.47) ADORA2AADORA2B
SCHEMBL20400772 0.75 ADORA2A (0.51) ADORA2AADORA2B
SCHEMBL20401483 0.73 ADORA2A (0.47) ADORA2AADORA2B
SCHEMBL31440894 0.72 ADORA2B (1.00) ADORA2AADORA2B
SCHEMBL31440983 0.72 ADORA2A (1.00) ADORA2AADORA2B
SCHEMBL20436396 0.68 ADORA2A (0.63) ADORA2AADORA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018136700-A1 AZOLOPYRIMIDINE FOR THE TREATMENT OF CANCER-RELATED DISORDERS ARCUS BIOSCIENCES, INC. (US) 2018-07-26 — — WO disclosed
Send feedback